(Q50638446)

English

Two-year treatment of Alzheimer's disease with eptastigmine. The Eptastigmine Study Group.

scientific article published in March 1999

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

title

Two-year treatment of Alzheimer's disease with eptastigmine. The Eptastigmine Study Group. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

1 reference

B P Imbimbo

1

1 reference

stated in

ORCID Public Data File 2021

author name string

G Verdelli

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

P Martelli

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

D Marchesini

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

publication date

1 March 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

published in

Dementia and Geriatric Cognitive Disorders

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

volume

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

page(s)

139-147

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

Identifiers

DOI

10.1159/000017114

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

PubMed publication ID

10026388

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10026388

retrieved

17 March 2018

reference URL

http://europepmc.org/abstract/MED/10026388

(Q50638446)

Two-year treatment of Alzheimer's disease with eptastigmine. The Eptastigmine Study Group.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)